Astrogen, inc.
Daegu
About Astrogen, inc.
Astrogen, inc. is a South Korea-based biopharmaceutical company specializing in the development of innovative small molecule therapies for neurological and rare diseases. Founded in 2017 by a pediatric neurologist, Astrogen leverages its clinical expertise and cutting-edge research to address unmet medical needs in conditions such as Autism Spectrum Disorder (ASD), Rett syndrome, Parkinson’s disease, and more.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $33.1M
- Funding stage: Late Stage Venture
- Last round: Series C (Jan 2024)
- Website: astrogen.co.kren
- Phone: +82 53 254 8850
Industries & Categories
Biotechnology, Neuroscience, Pharmaceutical, Product Research
Social Profiles
Canonical: https://fsome.com/organization/astrogen-inc-95646 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.